Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs
Advocate General Francis Jacobs argued that drug makers should be allowed to use quotas to stop traders from buying excess drugs in low-priced countries in the European Union and selling them in higher-priced countries.
GlaxoSmithKline’s quotas "shouldn't be considered abusive where the differences in prices of medicines between (E.U. countries) are the...
To view the full article, register now.